What does CUSIP 74587V107 represent in this 13F holders report?

CUSIP 74587V107 is the security identifier for PBYI - PUMA BIOTECHNOLOGY, INC. - Common Stock used to aggregate holder disclosures.

How many institutions held PBYI - PUMA BIOTECHNOLOGY, INC. - Common Stock in Q4 2014?

183 institutional investors reported PBYI - PUMA BIOTECHNOLOGY, INC. - Common Stock for Q4 2014. Use the holders table for investor-level position and value details.

PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI)

CUSIP: 74587V107

Q4 2014 13F Holders as of 31 Dec 2014

Type / Class: Equity / Common Stock
Shares outstanding: 49,633,071
Total 13F shares: 27,148,671
Share change: +460,319
Total reported value: $5,140,326,488
Put/Call ratio: 153%
Price per share: $189.27
Number of holders: 183
Value change: +$68,524,432
Number of buys: 104
Number of sells: 85

Quarterly Holders Quick Answers

What is CUSIP 74587V107?
CUSIP 74587V107 identifies PBYI - PUMA BIOTECHNOLOGY, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2015
Previous quarter: Q3 2014

Recent filing periods for CUSIP 74587V107:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of PBYI - PUMA BIOTECHNOLOGY, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	11%	5,686,668	$1,356,668,000	—	30 Sep 2014	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	7.1%	3,539,423	$844,400,000	—	30 Sep 2014	13F
FMR LLC	13F	Company	5.6%	2,789,515	$665,494,000	—	30 Sep 2014	13F
Capital Research Global Investors	13F	Company	3.7%	1,835,500	$437,895,000	—	30 Sep 2014	13F
VANGUARD GROUP INC	13F	Company	3%	1,501,216	$358,146,000	—	30 Sep 2014	13F
BlackRock Institutional Trust Company, N.A.	13F	Company	1.1%	553,410	$132,027,000	—	30 Sep 2014	13F
BlackRock Fund Advisors	13F	Company	1.1%	536,506	$127,994,000	—	30 Sep 2014	13F
WELLS FARGO & COMPANY/MN	13F	Company	1.1%	531,102	$126,704,000	—	30 Sep 2014	13F
FRANKLIN RESOURCES INC	13F	Company	1.1%	523,444	$124,878,000	—	30 Sep 2014	13F
LORD, ABBETT & CO. LLC	13F	Company	1%	511,716	$122,080,000	—	30 Sep 2014	13F
Cormorant Asset Management, LP	13F	Company	1%	507,500	$121,074,000	—	30 Sep 2014	13F
BB BIOTECH AG	13F	Company	0.96%	476,991	$113,796,000	—	30 Sep 2014	13F
STATE STREET CORP	13F	Company	0.93%	459,468	$109,616,000	—	30 Sep 2014	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.79%	392,776	$93,705,000	—	30 Sep 2014	13F
MASSACHUSETTS FINANCIAL SERVICES CO /MA/	13F	Company	0.76%	377,959	$90,170,000	—	30 Sep 2014	13F
CITADEL ADVISORS LLC	13F	Company	0.65%	322,989	$77,055,000	—	30 Sep 2014	13F
FEDERATED HERMES, INC.	13F	Company	0.6%	298,892	$71,307,000	—	30 Sep 2014	13F
JANUS HENDERSON INVESTORS US LLC	13F	Company	0.6%	297,425	$70,957,000	—	30 Sep 2014	13F
JPMORGAN CHASE & CO	13F	Company	0.56%	275,959	$65,835,000	—	30 Sep 2014	13F
NORTHERN TRUST CORP	13F	Company	0.53%	261,318	$62,343,000	—	30 Sep 2014	13F
BLACKROCK ADVISORS LLC	13F	Company	0.47%	231,246	$55,169,000	—	30 Sep 2014	13F
EAGLE ASSET MANAGEMENT INC	13F	Company	0.46%	227,470	$54,267,000	—	30 Sep 2014	13F
ORBIS HOLDINGS LTD	13F	Company	0.44%	217,262	$51,832,000	—	30 Sep 2014	13F
ORBIMED ADVISORS LLC	13F	Company	0.43%	212,900	$50,792,000	—	30 Sep 2014	13F
FRONTIER CAPITAL MANAGEMENT CO LLC	13F	Company	0.42%	209,630	$50,011,000	—	30 Sep 2014	13F
FRED ALGER MANAGEMENT, LLC	13F	Company	0.33%	161,904	$38,625,000	—	30 Sep 2014	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.32%	160,721	$38,343,000	—	30 Sep 2014	13F
NORGES BANK	13F	Company	0.32%	157,081	$37,475,000	—	30 Sep 2014	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.31%	155,600	$37,121,000	—	30 Sep 2014	13F
Bank of New York Mellon Corp	13F	Company	0.26%	127,267	$30,363,000	—	30 Sep 2014	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.25%	122,635	$29,256,000	—	30 Sep 2014	13F
Allianz Asset Management GmbH	13F	Company	0.22%	109,031	$26,012,000	—	30 Sep 2014	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.22%	108,644	$25,919,000	—	30 Sep 2014	13F
Capital World Investors	13F	Company	0.21%	104,734	$24,986,000	—	30 Sep 2014	13F
WEATHERBIE CAPITAL, LLC	13F	Company	0.2%	101,055	$24,109,000	—	30 Sep 2014	13F
RS INVESTMENT MANAGEMENT CO LLC	13F	Company	0.19%	92,188	$21,993,000	—	30 Sep 2014	13F
LOOMIS SAYLES & CO L P	13F	Company	0.18%	87,687	$20,919,000	—	30 Sep 2014	13F
TimesSquare Capital Management, LLC	13F	Company	0.17%	86,250	$20,577,000	—	30 Sep 2014	13F
COLUMBUS CIRCLE INVESTORS	13F	Company	0.17%	84,652	$20,195,000	—	30 Sep 2014	13F
TEACHERS ADVISORS, LLC	13F	Company	0.16%	79,179	$18,890,000	—	30 Sep 2014	13F
BlackRock Investment Management, LLC	13F	Company	0.15%	76,278	$18,198,000	—	30 Sep 2014	13F
PUTNAM INVESTMENTS LLC	13F	Company	0.14%	71,118	$16,967,000	—	30 Sep 2014	13F
Nationwide Fund Advisors	13F	Company	0.14%	70,232	$16,755,000	—	30 Sep 2014	13F
TD ASSET MANAGEMENT INC	13F	Company	0.14%	70,000	$16,700,000	—	30 Sep 2014	13F
DEUTSCHE BANK AG\	13F	Company	0.13%	66,907	$15,960,000	—	30 Sep 2014	13F
Neuberger Berman Group LLC	13F	Company	0.13%	66,664	$15,904,000	—	30 Sep 2014	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.13%	64,677	$15,430,000	—	30 Sep 2014	13F
LMR Partners LLP	13F	Company	0.11%	56,632	$13,510,000	—	30 Sep 2014	13F
OppenheimerFunds, Inc.	13F	Company	0.11%	54,600	$13,026,000	—	30 Sep 2014	13F
Redmile Group, LLC	13F	Company	0.1%	51,025	$12,173,000	—	30 Sep 2014	13F

Institutional Holders of PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI) as of Q4 2014

As of 31 Dec 2014, PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI) was held by 183 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 27,148,671 shares. The largest 10 holders included ADAGE CAPITAL PARTNERS GP LLC, FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, Capital Research Global Investors, VANGUARD GROUP INC, BlackRock Fund Advisors, BlackRock Institutional Trust Company, N.A., BB Biotech AG, Capital International Investors, and State Street Corp. This page lists 183 institutional shareholders reporting positions in this security for the Q4 2014 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2014 vs Q3 2014 Across Filers

Q3 2014 holders

182

Q4 2014 holders

183

Holder diff

Investor	Q3 2014 Shares	Q4 2014 Shares	Share Diff	Share Chg %	Q3 2014 Value $	Q4 2014 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.